atai Life Sciences (ATAI) News Today $2.68 +0.06 (+2.10%) As of 12:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATAI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Aegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 TargetJuly 11 at 12:23 AM | finance.yahoo.comCanaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)’s Price Target To $12, Maintains Buy RatingJuly 9, 2025 | finance.yahoo.comRetail investors are Atai Life Sciences N.V.'s (NASDAQ:ATAI) biggest owners and were rewarded after market cap rose by US$121m last weekJuly 3, 2025 | uk.finance.yahoo.comatai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression - NasdaqJuly 2, 2025 | nasdaq.comatai Life Sciences price target boosted on robust BPL-003 mid-stage trial resultsJuly 2, 2025 | proactiveinvestors.comAtai: Critical Study Win Sets Up Double Approval Shot For Psychedelics In TRDJuly 2, 2025 | seekingalpha.comAtai and Beckley Psytech hail DMT trial results in treatment-resistant depressionJuly 2, 2025 | proactiveinvestors.comatai and Beckley Psytech’s psychedelic wins in Phase IIb depression trialJuly 1, 2025 | finance.yahoo.comAtai Shares Hit 2-Year High on Positive Trial Results, $50M FinancingJuly 1, 2025 | marketwatch.comAtai and Beckley, set to merge, reveal study success for psychedelic drugJuly 1, 2025 | finance.yahoo.comAtai Shares Rise on Beckley’s Psychedelic Drug Study SuccessJuly 1, 2025 | bloomberg.comAtai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage DataJuly 1, 2025 | benzinga.comATAI Life Sciences stock soars after positive Phase 2b depression drug resultsJuly 1, 2025 | in.investing.comAtai rises as psychedelic drug succeeds in mid-stage trial for depressionJuly 1, 2025 | msn.comATAI Life Sciences Shares Soar Following Strong Phase 2b Results for Depression TreatmentJuly 1, 2025 | msn.comatai Life Sciences Announces $50 Million Private Placement FinancingJuly 1, 2025 | globenewswire.comatai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant DepressionJuly 1, 2025 | globenewswire.comATAI - ATAI Life Sciences NV Price vs Fair Value - MorningstarJune 27, 2025 | morningstar.comMATAI - ATAI Life Sciences NV Valuation - MorningstarJune 27, 2025 | morningstar.comMMaxim Group Maintains a Buy on Atai Life Sciences (ATAI) With a $6 Price TargetJune 24, 2025 | msn.comatai Life Sciences backed by positive sector readthrough from Compass Phase 3 data, analysts sayJune 23, 2025 | proactiveinvestors.comPsychedelics regain momentum in 2025 on political tailwinds, clinical winsJune 19, 2025 | proactiveinvestors.comFDA seen likely to grant emergency use authorizations for psychedelics, boosting sector stocksJune 18, 2025 | proactiveinvestors.comFDA seen likely to grant emergency use authorizations for psychedelics, boosting sector stocksJune 18, 2025 | proactiveinvestors.comHAPPY FATHER'S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Atai Life Sciences N.V.June 15, 2025 | globenewswire.comATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to ShareholdersJune 3, 2025 | businesswire.comAtai Life Sciences Stock Rockets On Merger Plans With Beckley Psytech; Retail Traders Eye Every DipJune 3, 2025 | msn.comATAI Life Sciences stock soars on Beckley Psytech merger dealJune 2, 2025 | investing.comATAI Life Sciences Shares Rise on Merger Deal with Beckley PsytechJune 2, 2025 | marketwatch.comATAI Life Sciences Shares Jump Following Merger Announcement with Beckley PsytechJune 2, 2025 | msn.comatai Life Sciences gains maximum exposure to key psychedelic asset with Beckley Psytech mergerJune 2, 2025 | proactiveinvestors.comatai Life Sciences and Beckley Psytech to merge in all-share deal, stock popsJune 2, 2025 | proactiveinvestors.comThiel-Backed Psychedelic Drugmaker Atai to Combine With BeckleyJune 2, 2025 | bloomberg.comatai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health TherapiesJune 2, 2025 | globenewswire.comatai Life Sciences expects key trial data by mid-2025 - ICYMIMay 31, 2025 | proactiveinvestors.comatai Life Sciences to Participate in Upcoming Investor ConferencesMay 29, 2025 | globenewswire.comatai Life Sciences holds annual general meetingMay 23, 2025 | investing.comPhase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says JefferiesMay 21, 2025 | finance.yahoo.comAtai Life Sciences Stock Soars To 3-Month High As Depression Study Yields Promising Results: Retail Bulls CheerMay 21, 2025 | msn.comatai Life Sciences upside highlighted by analysts as more positive data backs Beckley Psytech's depression therapyMay 20, 2025 | proactiveinvestors.comatai Life Sciences reports positive data from mid-stage depression trialMay 20, 2025 | msn.comatai Life Sciences announces positive topline data from Phase 2a treatment-resistant depression studyMay 20, 2025 | proactiveinvestors.comatai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech's Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant DepressionMay 20, 2025 | globenewswire.comatai Life Sciences shares gain momentum ahead of pivotal trial readoutsMay 15, 2025 | proactiveinvestors.comAtai Life Sciences: Progress in Psychedelic Mental Health TreatmentsMay 14, 2025 | tipranks.comatai Life Sciences Initiates Phase 2 Study of EMP-01 for Social Anxiety DisorderMay 14, 2025 | nasdaq.comatai Life Sciences builds clinical momentum in first quarter of 2025May 14, 2025 | proactiveinvestors.comatai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate UpdatesMay 14, 2025 | globenewswire.comatai Life Sciences doses first patient in Phase 2 social anxiety trialMay 13, 2025 | proactiveinvestors.comatai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety DisorderMay 13, 2025 | globenewswire.com Get atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address ATAI Media Mentions By Week ATAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATAI News Sentiment▼0.441.01▲Average Medical News Sentiment ATAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATAI Articles This Week▼33▲ATAI Articles Average Week Get atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NAMS News Today TWST News Today DNLI News Today KNSA News Today AGIO News Today VCEL News Today CGON News Today RXRX News Today BEAM News Today BLTE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATAI) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding atai Life Sciences N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATAI Stock Alerts